EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib By Ogkologos - May 22, 2026 99 0 Facebook Twitter Google+ Pinterest WhatsApp Palbociclib Viatris is a generic of Ibrance which has been authorised in the EU since 2016 Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Update Shows Long-Term Survival Benefit with Abemaciclib Plus Fulvestrant in HR-positive,... November 21, 2020 Sister Is There To Comfort Her Little Brother As He Battles... September 10, 2019 Singer Surprises 6-Year-Old Fan Who Beat Cancer With Trip To Disney January 10, 2022 Isolated Hepatic Perfusion with Melphalan Improves Response Rate and PFS in... April 5, 2023 Load more HOT NEWS Cholesterol Drug May Help Protect the Heart during Chemotherapy for Lymphoma EMA Recommends Granting a Conditional Marketing Authorisation for Trastuzumab Deruxtecan New Immunotherapy Option Approved for Cervical Cancer, Rare Lymphoma Texas Baby Is Born With Almost No Skin On His Body,...
